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Abstract
Background: Naturally occurring thymus derived regulatory T cells (Tregs) are central in the maintenance of self-tolerance.
The transcription factor FOXP3 is crucial for the suppressive activity of Tregs and is considered the most specific marker for
this population. However, human non regulatory T cells upregulate FOXP3 transiently upon activation which calls for other
means to identify the Treg population. Since epigenetic mechanisms are involved in the establishment of stable gene
expression patterns during cell differentiation, we hypothesized that the methylation profile of the FOXP3 promoter would
allow the distinction of truly committed Tregs.
Methodology/Principal Findings: Human CD4
+CD25
hi Tregs displayed a demethylated FOXP3 promoter (1.4%60.95% SEM
methylated) in contrast to CD4
+CD25
lo T cells which were partially methylated (27.9%67.1%). Furthermore, stimulated
CD4
+CD25
lo T cells transiently expressed FOXP3 but remained partially methylated, suggesting promoter methylation as a
mechanism for regulation of stable FOXP3 expression and Treg commitment. In addition, transient FOXP3 expressing cells
exhibited suppressive abilities that correlate to the methylation status of the FOXP3 promoter. As an alternative to
bisulphite sequencing, we present a restriction enzyme based screening method for the identification of committed Tregs
and apply this method to evaluate the effect of various culturing conditions. We show that a partial demethylation occurs in
long-term cultures after activation, whereas the addition of TGF-b and/or IL-10 does not induce any additional change in
methylation level.
Conclusions/Significance: The unique FOXP3 promoter methylation profile in Tregs suggests that a demethylated pattern is
a prerequisite for stable FOXP3 expression and suppressive phenotype. Presently, FOXP3 is used to identify Tregs in several
human diseases and there are future implications for adoptive Treg transfer in immunotherapy. In these settings there is a
need to distinguish true Tregs from transiently FOXP3
+ activated T cells. The screening method we present allows this
distinction and enables the identification of cells suitable for in vitro expansions and clinical use.
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Introduction
Human immunity is an intriguingly complex balance of self
defence versus autoreactivity. Naturally occurring thymus-derived
Tregs are a subpopulation of T cells which play a central role as
regulators of immune response. The transcription factor FOXP3
has been linked to the suppressive phenotype of both human
(FOXP3) and murine (Foxp3) Treg populations [1–4]. Mutations
in the human FOXP3 gene causes the disease Immune dysregu-
lation, Polyendocrinopathy, Enteropathy, X-linked syndrome
(IPEX) [5], and the Foxp3 mutant Scurfy mouse model displays a
similar pathology involving dysregulated CD4
+ T cell infiltration
and activation [6–8]. Although transient expression of Foxp3 has
been observed in murine activated T cells [9], Foxp3 is not only
considered a specific marker for the Treg population but it is also
required and sufficient for Treg development in the murine setting
[1,3]. In humans however, recent reports indicate that FOXP3
may not be as specific as its murine counterpart. Just as CD25,
FOXP3 is transiently upregulated in human CD4
+CD25
lo T cells
upon activation [10–15] and although this FOXP3 expression is
associated with hyporesponsiveness and decreased cytokine
production, results regarding the suppressive ability of these cells
differ [14,16,17]. The transduction of CD45RA
+CD4
+CD25
lo
with a FOXP3-encoding retrovirus resulted in significant FOXP3
expression, however this was not sufficient to induce a suppressive
phenotype or upregulation of Treg surface markers [16].
Presently, FOXP3 is used to identify Treg cells in several human
diseases including autoimmune conditions [18,19], infections
[20,21] and cancer [22]. In these settings, there is a need for
Treg markers able to distinguish this cell population from
activated T cells.
Considering the importance of FOXP3 in the control of immune
responses, the factors which in turn control FOXP3 become of
interest. The FOXP3 promoter region was recently described and
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CD4
+CD25
hi and CD4
+CD25
lo T cells [11]. It was also found to
contain binding sites for nuclear factor of activated T cells (NFAT)
and activator protein 1 (AP-1), transcription factors which are well-
established mediators of T cell activation, in agreement with the
possibility of FOXP3 transcription in activated CD4
+CD25
lo Tc e l l s
[11] as well as the fact that Tregs need to be activated in order to
acquire suppressor function [23].
Epigenetic control is a well-established means of gene regulation
within the immune system. Mechanisms such as histone
modifications and DNA methylation carefully govern cell fate
decisions in developing lymphocytes [24–26]. The epigenetic
mechanisms involved in Th1 and Th2 development are well
described, whereas the mechanisms controlling Treg development
are just beginning to be explored. Mice studies have focused on a
conserved element in intron one of the Foxp3 gene which shows
transcriptional activity and differential methylation between
CD4
+CD25
2 and T regulatory cells [27,28]. However, the
methylation status of the human FOXP3 promoter has not yet
been examined. The observation that human NK cells show
increased FOXP3 expression when treated with the demethylating
reagent 5-aza-29-deoxycytidine strongly supports the assumption
that FOXP3 expression is methylation dependent [29].
In this report, we investigated the epigenetic status of the human
FOXP3 promoter region, and correlated CpG methylation to
FOXP3 expression with the aim to identify putative methylation
sites to be used as Treg markers. We report Treg associated
demethylation in the FOXP3 promoter and identify a suitable site for
methylation based screening of Treg commitment. Furthermore, we
evaluate the demethylating abilities of several different stimuli and
culturing conditions. In conclusion, complete demethylation of the
human FOXP3 promoter is confined to committed Tregs and thus
analysis of promoter methylation enables the identification of cells
suitable for in vitro expansions and clinical use.
Results
Isolation and Analysis of Cell populations
PBMC from healthy blood donors were recovered from buffy
coats. Subsequently, CD4
+ T cells were isolated and analyzed with
respect to expression of CD4, CD25 and FOXP3 (Figure 1A–B).
In agreement with previous results [30], FOXP3 expression was
prominent in the CD4
+CD25
hi T cell population, with very few
CD4
+CD25
lo/int cells being FOXP3
+. As a control the CD19
+ B
cell population was found to be FOXP3
2 (Figure 1A–B). After cell
sorting, cell populations were .95% pure as demonstrated with
FACS (Figure 1A).
Confirmation of Treg Function and Analysis of FOXP3
Expression
Next the functionality of sorted Tregs was tested. The ability of
sorted CD4
+CD25
+ cells to suppress the proliferation of anti-CD3
and anti-CD28 activated CD4
+CD25
2 cells was investigated by
co-culture experiments measuring proliferation by [
3H]Thymidine
incorporation (Figure 1C). Suppressive effect of the CD4
+CD25
+
Treg cells was noted already at the ratio of one to four
CD4
+CD25
+ Treg cells to CD4
+CD25
2 T responder cells in
consistency with previous reports [23].
To confirm the Treg nature of sorted CD4
+CD25
+ cells FOXP3
mRNA expression was measured by quantitative real-time PCR.
The levels of FOXP3 transcripts were 75-fold elevated in isolated
CD4
+CD25
hi cells when compared to expression in CD4
+CD25
lo
cells. Conversely, the CD19
+ B cells displayed no detectable
FOXP3 mRNA expression (Figure 1D). Thus sorted CD4
+CD25
hi
T cells demonstrate a functional suppressive phenotype and
display a high FOXP3 mRNA expression.
Identification of evolutionarily conserved CpG’s in the
FOXP3 promoter
The functional human FOXP3 promoter has been previously
defined[11].Theregionprecedingthe59untranslatedregion(UTR)
is highly conserved and contains important promoter elements such
as TATA, GC and CAAT boxes as well as binding sites for NFAT
and AP-1, well-established mediators of T cell activation (Figure 2B).
The high degree of conservation of such cis-acting motifs in this
region (Figure 2A) indicated that it might be under epigenetic
influence. Therefore we investigated the FOXP3 promoter region
with regards to CpG dinucleotides using ClustalW alignment
comparing human, mouse and rat sequences (Figure 2C). The
wholepromoterregionshowed amouse tomanconservationof87%
(online supplemental material Figure S1), whereas the CpG
containing region was 92% conserved, stressing its evolutionary
importance (online supplemental material Figure S2). Moreover,
ClustalW alignment determined that out of eight tightly positioned
CpG dinucleotides just upstream of the transcription start site,
positions 243, 265 and 277 were totally conserved between
species. As these CpGs mapped just downstream of the binding sites
forthetranscriptionfactorsNFATandAP-1(Figure2B–C),aspecial
interest in these positions was rendered.
Methylation Status of the FOXP3 promoter
The putative methylation sites within the promoter region
prompted the investigation of the methylation status of these
positions by bisulphite sequencing. Cells were isolated from male
donors only in order to avoid possible artefacts due to random X
chromosome inactivation in females. CD4
+CD25
hi FOXP3
+ T
cells (n=18) were found to contain overall unmethylated CpGs
(Figure 3A), whereas CD19
+FOXP3
2 B cells (n=20) displayed a
fully methylated configuration (Figure 3C). The CD4
+CD25
lo
population (n=17) displayed an intermediate level of methylation
(Figure 3B), and differed significantly from the CD4
+CD25
hi
FOXP3
+ population at CpG positions 2113, 277, 265, and 258
as detailed in Table 1. Interestingly, the difference was most
pronounced (p,0.001) at the evolutionary conserved site CpG
position 277 (Figure 3D–F). The p-values of each position clearly
demonstrate the differences between the populations (Table 1).
Overall the CD4
+CD25
hi Treg cells demonstrated a low level of
methylation (1.4%60.95% SEM) at the CpG sites investigated. In
contrast, the CD4
+CD25
lo population was methylated to
27.9%67.1% and the CD19
+ B cells were almost completely
methylated (93.8%61.7%). Taken together these data show
significant differences in the degree of methylation in the FOXP3
promoter region, where the Treg population is unmethylated and
CD4
+CD25
lo T cells and CD19
+ B cells demonstrate increasing
levels of methylation.
COBRA Based Methylation Screening
Bisulphite sequencing is in itself both time-consuming and
limited by the number of clones analyzed in its ability to reflect the
true methylation status of a cell population. Therefore, we
developed a COBRA based method of screening the methylation
status at the evolutionary conserved CpG position 277 in the
FOXP3 promoter region. The method was tested on ex vivo
collected cell populations, with methylase treated and untreated
BAC as controls (Figure 4). Multiple peaks (separated by less than
3 bp) observed in the electropherograms are likely due to
exonuclease activity and/or star activity during the digestion.
FOXP3 Demethylation in Tregs
PLoS ONE | www.plosone.org 2 February 2008 | Volume 3 | Issue 2 | e1612Figure 1. FOXP3 expression in sorted cell populations and confirmation of Treg function. (A) The sorted CD4
+CD25
lo, CD4
+CD25
hi and
CD19
+ cells were analyzed by flow cytometry. (B) FOXP3 expression in the sorted populations as determined by intracellular flow cytometry. Plots
showing results from one representative donor out of four analyzed, except for plot showing FOXP3 expression in CD19
+ cells where one single
donor was analyzed (C) Sorted CD4
+CD25
+ cells suppress the proliferation of CD4
+CD25
2 cells. CD4
+CD25
2 cells were activated with CD3 and CD28
antibodies together with CD4
2 feeder cells and increasing numbers of CD4
+CD25
+ cells in triplicate samples. Proliferation was measured as
incorporation of [
3H]Thymidine for 18 hours, here illustrated as counts per minute (cpm) on the y-axis. The CD4
+CD25
+ to CD25
2 cell ratio is
displayed on the x-axis. Squares indicate coculture of CD25
2 and CD25
+ cells. Triangles indicate control samples with only CD4
+CD25
2 cells. (D)
FOXP3 mRNA expression of sorted cell populations. FOXP3 mRNA was measured by real-time PCR in FACS sorted CD4
+CD25
hi, CD4
+CD25
lo and CD19
cells. Data was normalized to the expression in CD4
+CD25
lo cells using the 2
2DDCt method and RPII as housekeeping gene. Data represent mean of
triplicate samples from one single donor.
doi:10.1371/journal.pone.0001612.g001
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PLoS ONE | www.plosone.org 3 February 2008 | Volume 3 | Issue 2 | e1612Figure 2. Identification of cross-species conserved FOXP3 promoter elements. (A) FOXP3 transcript and m-Vista alignment showing
conservation between human and mouse genomic sequences. Dark blue boxes display exons, outlined boxes are UTR’s. Conserved regions are in red
and conserved regions corresponding to exons are in light blue. (B) Schematic view of the conserved region upstream of the transcription start site
indicating the location of promoter elements and CpG dinucleotides. (C) Clustal W alignment of human, mouse and rat genomic sequences showing
a detailed view of the conservation at the FOXP3 core promoter. The broken arrow shows the position of the human transcription start site. The
location of the TATA box is indicated by a black box. Red boxes indicate the CpG dinucleotides analyzed in this study. Transcription factor binding
sites are marked with grey boxes.
doi:10.1371/journal.pone.0001612.g002
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+CD25
hi
Tregs remained undigested (Figure 4A top panel) in agreement
with the results derived from the unmethylated BAC control
(Figure 4A bottom panel). The methylated BAC was .90%
digested as well as the methylated promoter region derived from
sorted CD19
+ B cells (Figure 4A third panel from the top). In
concordance with the sequencing data CD4
+CD25
lo T cells
displayed a partially unmethylated 277 CpG position (Figure 4A
second panel from the top). Thus investigating the 277 reporter
CpG position (Figure 4B) mirrors the results obtained by bisulphite
sequencing confirming the validity of the method.
FOXP3 Expression in Activated T cell Populations
Previously, activated CD4
+CD25
lo cells have been shown to
transiently upregulate FOXP3 [13,14]. Therefore, we stimulated
CD4
+CD25
lo T cells with anti-CD3/CD28 Dynabeads for
48 hours and monitored the expression of FOXP3 and CD25
up to day 16 of culture (Figure 5A). Mean fluorescent intensity
(MFI) for FOXP3 and CD25 expression at each time point was
calculated (Figure 5B). CD25 showed a faster response to TCR
stimulation in comparison to FOXP3. Maximum MFI of FOXP3
was recorded day 5 of culture after which it decreased. However,
the cells still displayed some residual FOXP3 expression at day 16.
These results confirm that FOXP3 expression occurs in
CD4
+CD25
lo T cells upon stimulation, and thus is not solely
limited to the Treg population in humans.
Methylation of the FOXP3 promoter during T cell
activation
In order to investigate whether the transient expression of
FOXP3 during T cell activation was associated with FOXP3
promoter demethylation, we analyzed male CD4
+CD25
lo cells
with respect to their methylation status during stimulation
(Figure 6A). Cells were stimulated as previously described and
DNA from the CD4
+CD25
hi and CD4
+CD25
lo fraction of the
culture was extracted at day 5, 7, 12 and 16. The methylation
status of the FOXP3 promoter was analyzed using the restriction
enzyme based method described above. In addition, stimulated
CD4
+CD25
hi cells isolated at day 0 was included in the
experiment to show whether thymus derived T regulatory cells
would maintain a demethylated FOXP3 promoter during the
course of stimulation and expansion. Interestingly, an initial
Figure 3. Tregs are unmethylated at the FOXP3 promoter region. Bars in (A) to (C) indicate the percentage of methylated (black) and
unmethylated (white) cells at each CpG position (specified on x-axis labels as relative the transcription start site) in (A) CD4
+CD25
hi, (B) CD4
+CD25
lo
and (C) CD19
+ cell populations isolated by FACS from one male donor. (D) to (F) Methylation grade of the most discriminating CpG position (277).
Percentage methylated (filled) versus unmethylated (open) CpGs in the (D) CD4
+CD25
hi, (E) CD4
+CD25
lo and (F) CD19
+ cells.
doi:10.1371/journal.pone.0001612.g003
Table 1. P-value for each CpG position in sorted cells.
2138 2126 2113 277 265 258 243 215
CD25
hi vs CD25
lo 0.47 0.15 ,0.05 ,0.001 ,0.01 ,0.05 0.10 0.23
CD25
lo vs CD19
+ ,0.001 ,0.001 ,0.001 ,0.05 ,0.001 ,0.001 ,0.001 ,0.001
CD25
hi vs CD19
+ ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
doi:10.1371/journal.pone.0001612.t001
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+CD25
lo
derived CD25
hi and lo cells was observed at day 5. The methylation
level of the CD25
hi and lo CD4
+CD25
lo derived cells gradually
converged and levelled off at about 60% at day 16. Stimulated T
regulatory cells however, maintained their demethylated profile
although a slight increase in methylation could be seen. This is most
probably explained by a small number of contaminating non-Tregs
in the starting culture, which naturally respond more readily to
stimuli and thus proliferate faster relative the Treg population.
FOXP3 expression was also measured using intracellular flow
cytometry in all populations (Figure 6B). The highest levels of
FOXP3 were observed in the stimulated Treg population. The
CD25
hi fraction of the CD25
lo derived cells displayed higher levels
of FOXP3 expression than the CD25
lo fraction throughout the
course of stimulation.
The methylation level of the FOXP3 promoter region during
transient expression was also determined in one donor using
bisulphite sequencing (online supplemental material Figure S3A).
Demethylation was detected after 2 and 12 days of culture (online
supplemental material Table S1) in agreement with the results
using the COBRA based technique (Figure 6A). On day 12 the
bulk of cells we sorted into CD4
+CD25
lo and CD4
+CD25
hi
populations and processed as previously described (online
supplemental material Figure S3B). These populations displayed
no significant difference in FOXP3 promoter metylation.
Suppressive ability of induced FOXP3
+ cells
The transient expression of FOXP3 in activated T cells has been
proposed as a mechanism of attenuating the activated state in these
cells, but whether activated transient FOXP3 expressing T cells also
have the capacity to suppress neighbouring cells is an unresolved
matter [13–15,17]. During the transient expression of FOXP3 we
observe maximum MFI at day 5 of culture (Figure 5B). Therefore,
this time point was chosen to evaluate the suppressive capacity of
transient FOXP3 expressing cells. At day 5 of culture, the activated
pool of cells contains a mixture of CD25
hi and CD25
lo cells with
differing levels of methylation (Figure 6A) wherefore the suppressive
capacity of these populations was measured separately. Suppressive
capacity was determined based upon the ability to suppress the
proliferation of CFSE stained CD4
+ Tc e l l s .H i g h e rs u p p r e s s i v e
capacity of the induced CD4
+CD25
hi cells was observed compared
to the CD4
+CD25
lo sorted fraction (Figure 6C). This is also in
agreement with the observation of higher FOXP3 expression among
these cells (Figure 6B).
Long-term follow-up after activation
CD4
+CD25
hi cells isolated from peripheral blood are
CD45RO
+ and CD45Rb
lo. They also have short telomere length
consistent with memory T cells that have undergone several
rounds of replication [31]. These observations together with the
finding of antigen-specific Treg cells suggest that Tregs are
generated as a result of time, after one or repeated antigen
encounters. In order to investigate whether long-term culture after
stimulus or repeated stimuli over time could affect the methylation
Figure 4. Restriction enzyme based analysis of the methylation
status at the FOXP3 277 reporter position. PCR product from
bisulphite treated DNA was digested with the restriction enzyme Aci1,
which only cleaves DNA at position 277 in the FOXP3 promoter when
DNA originally was methylated. Digestion was followed by GeneScan
analysis. (A) Electropherograms showing peaks from the Aci1 digestion
product. Amounts of digested and undigested product were calculated
r
as area under the curve. Shown are results from one representative
donor out of three analyzed, except for electropherogram obtained
from CD19
+ cells where one single donor was analyzed. Digestion
product from methylated and unmethylated BAC was analyzed three
times with similar results. (B) Filled bars indicate percentage methyl-
ated, and open bars percentage unmethylated 277 sites. Methylase
treated and unmodified BACs were used as controls.
doi:10.1371/journal.pone.0001612.g004
FOXP3 Demethylation in Tregs
PLoS ONE | www.plosone.org 6 February 2008 | Volume 3 | Issue 2 | e1612Figure 5. Transient expression of FOXP3 and CD25 in stimulated CD4
+CD25
lo cells from male donors. Plots showing results from one
representative donor out of four analyzed. (A) FACS analysis of CD4
+CD25
lo cells stimulated at day 0 with CD3/CD28 Dynabeads (proportion
cell:beads 1:1) in presence of 180 U IL-2. Stimuli removed after 48 h and cells followed for an additional 2 weeks with regards to their expression of
CD25 (left) and FOXP3 (middle). Left column demonstrating the relationship between CD25 (y-axis) and FOXP3 (x-axis) expression. (B) Expression of
CD25 (grey filled bars) and FOXP3 (open bars) in stimulated cells as described above, displayed as mean fluorescent intensity (MFI).
doi:10.1371/journal.pone.0001612.g005
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lo T cells demethylate during proliferation and exert suppressive activity in vitro. The methylation level of
activated cells derived from the CD25
lo population was monitored with the COBRA based analysis described in Figure 4. (A) Cultures from three
separate donors were setup and stimulated as in Figure 5, after which the methylation status in the CD25
hi and CD25
lo fraction was monitored for
16 days. Cultures of T regulatory cells from two donors were kept in parallel and likewise analyzed with respect to methylation at day 0 as well as
indicated time points. Shown are mean values6SEM. (B) FOXP3 expression in the CD25
hi and CD25
lo cells isolated at day 0 was determined by
intracellular flow cytometry (left graph). During activation, FOXP3 expression was also determined in the sorted populations derived from stimulated
CD25
lo cells (right graph). Data represent mean values from three separate donors6SEM. (C) CD25
hi and CD25
lo cells from three donors were isolated
on day 5 post-activation. To examine the suppressive capacity of these activated CD25
lo derived cells, they were put into co-culture with autologous
CFSE-stained non-activated CD4
+ T cells in the presence of anti-CD3 and anti-CD28 antibodies, and autologous CD4
2 cells as feeder cells. A control
sample was included for each donor where only responder and feeder cells were included in the culture. Suppressive activity was evaluated on day 3
of co-culture as the mean fluorescence intensity ratio of CFSE
+ responder cells in each sample relative the control sample.
doi:10.1371/journal.pone.0001612.g006
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+CD25
lo cells we
followed the expression of CD25 and FOXP3 with FACS while
monitoring the methylation status with the COBRA based method
(figure 7A and D). Stimulation with CD3/CD28 Dynabeads or
repeated stimulations with anti-CD3 and and-CD28 antibodies
induced a transient expression of CD25 and FOXP3 and a
gradual demethylation, similar to what was previously observed
(Figure 6A and B). It is also worth noting that the Treg population
remained FOXP3
hi throughout the stimulation.
It has been suggested that thymic derived T regulatory cells are
generated as a result of an antigenic encounter that is insufficient
to induce thymic deletion but sufficient to sustain a partial
activation [32]. The generation of Tregs during suboptimal stimuli
has also been suggested as a mechanism for inducing peripheral T
regulatory cells. In order to investigate whether subimmunogenic
conditions could be beneficial for a Treg like FOXP3 expression
and methylation profile we stimulated CD4
+CD25
lo cells with
anti-CD3 antibody in three different concentrations together with
anti-CD28 antibody. In all cases the stimulation resulted in a
transient CD25 and FOXP3 expression and a partial decrease in
methylation level as measured by the COBRA based method at
the 277 reporter position (figure 7B & E). Cells were also
stimulated with anti-CD3 or anti-CD28 alone. However, neither
of these conditions induced any evident changes in FOXP3
expression nor promoter methylation (data not shown).
Effect of TGF-b and IL-10 on methylation status
In mice, the conversion of CD4
+CD25
2 cells to the Treg
phenotype is dependent on the presence of TGF-b [33–36].
Moreover it was very recently shown that TGF-b was able to
induce demethylation at the mouse Foxp3 promoter during
activation of CD4
+CD25
2 cells [27]. In order to investigate if
TGF-b and/or IL-10, another Treg associated cytokine, have any
effects on FOXP3 promoter methylation in the human context we
stimulated CD4
+CD25
lo cells with anti-CD3 and anti-CD28
antibodies in the presence of TGF-b and/or IL-10. We monitored
CD25 and FOXP3 expression by flow cytometry and measured the
methylation status of the FOXP3 promoter at given time points (day
0, 7, 14 and 21) using the COBRA based method previously
described. Presence of TGF-b alone or together with IL-10 resulted
in a more prolonged FOXP3 expression as compared to IL-10 only
(figure 7C). However, no apparent difference in methylation status
could be seen as compared to the activated population grown
without the presence of TGF-b (figure 7F).
Figure 7. Activation results in a partial demethylation at long-term follow-up. CD25 and FOXP3 expression was monitored in CD4
+CD25
lo
cells during activation with (A) CD3/CD28 dynabeads as described in Figure 5 or repeated stimulation with anti-CD3 (5 mg/mL) and anti-CD28 (1 mg/
mL) antibodies every 7 days. CD4
+CD25
hi Tregs were also monitored as they were stimulated continuously with CD3/CD28 dynabeads. (B)
CD4
+CD25
lo cells stimulated with high (10 mg/mL), medium (5 mg/mL) or low (0.5 mg/mL) anti-CD3 antibody together with 1 mg/mL anti-CD28
antibody. (C) CD4
+CD25
lo cells stimulated with anti-CD3 (5 mg/mL) and anti-CD28 (1 mg/mL) antibodies together with TGF-b (5 ng/mL), TGF-b (5 ng/
mL) and IL-10 (10 ng/mL) or IL-10 only (10 ng/mL). Stimuli were removed on day 2 after stimulation and FACS analysis performed on days 0, 2, 5, 7,
10, 14 and 21. Data represent mean values from three separate donors6SEM, except for expanded Tregs where data represent mean values from two
separate donors. Methylation status of the 277 reporter position was monitored during conditions described above (D–F). Evaluation of methylation
status was performed on DNA from one donor at days 0, 7, 14 and 21 for each separate population. Methylation of expanded Tregs at day 7, 12 and
16 represent mean values from two separate donors.
doi:10.1371/journal.pone.0001612.g007
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We have investigated the methylation status of a collection of
tightly positioned conserved CpG dinucleotides in the FOXP3
promoter region demonstrating a pattern which distinguishes the
Treg population from induced FOXP3
hi T cells. Our data strongly
suggests that the transient FOXP3 expression by activated T cells,
observed by us and others, is a consequence of the methylation
status at the FOXP3 promoter region. Thus, only complete
demethylation of the conserved FOXP3 promoter region support
stable long term FOXP3 expression and a committed Treg
phenotype in humans.
Mantel and colleagues have demonstrated that a conserved
fragment of 348 bp upstream of the FOXP3 transcription start site
contains a minimal promoter necessary for induction of FOXP3
expression [11]. This region harbours important features of
eukaryotic promoters such as TATA, GC and CAAT boxes.
Disruption of these elements in reporter constructs resulted in
reduced activity of the core promoter. Furthermore, the core
promoter region contains functional binding sites for the
transcription factors NFAT and AP-1, well known mediators of
T cell activation [11]. We have analyzed the methylation status in
a stretch of 8 tightly positioned CpG dinucleotides located
between these transcription factor binding sites and the FOXP3
transcription start site. Naturally occurring T regulatory cells
displayed a completely demethylated promoter region while
induced CD4
+CD25
hi cells as well unstimulated and restimulated
CD4
+CD25
lo cells displayed a partially methylated promoter
region. Interestingly, the partially methylated state was mostly
pronounced at CpG position 277, which is fully conserved in
cross species comparisons between human, mouse and rat. This
emphasises the importance of the observed difference in
methylation at this site.
Floess et al. [28] recently identified another differentially
methylated region within the mouse Foxp3 locus. A CpG rich
region was found upstream of exon 1 displaying transcriptional
activity and a differential methylation pattern between
CD4
+CD25
+ and CD4
+CD25
2 cells. In a very recent report
Kim et al [27] showed that this region binds cAMP response
element binding protein (CREB) in a methylation dependent
manner. In agreement with our data, the authors also showed a
differential methylation state at the Foxp3 promoter region
between CD4
+CD25
+ and CD4
+CD25
2 cells and that treatment
of CD4
+CD25
2 cells with 5-azacytidine results in elevated Foxp3
expression and demethylation at the Foxp3 locus. Furthermore it
was shown that addition of TGF-b to cell cultures induced
demethylation at both the mouse promoter and the CREB binding
region. Our experiments, on the other hand, show that addition of
TGF-b during cell culture does not result in a Treg like
demethylation at the human FOXP3 promoter. In parallel to our
study, another group have observed similar results regarding
methylation in the conserved element upstream of exon 1 whitin
the human FOXP3 gene [37]. The observations of differing effects
of TGF-b on methylation status in human or mouse settings agree
with functional experiments conducted by others where it has been
shown that TGF-b can induce functional Tregs in mice [33–36]
but only transiently upregulates FOXP3 in humans and results in a
non suppressive phenotype [38].
FOXP3 is used as a specific marker for the identification of T
regulatory cells due to its correlation with suppressive function in
freshly isolated CD4
+CD25
+ cells. However, as we and others
have shown, FOXP3 is not restricted to naturally occurring Tregs
but can be expressed by conventional T cells upon stimulation
(Figure 4) [10–15,17]. The suppressive capacity of the induced
FOXP3 expressing cells has been tested with various results. In
most cases, stimulation resulted in a transient FOXP3 expression
and non suppressive function, however, suppressive phenotypes
have been observed [10,14–17,39]. Regardless whether the
variations in suppressive capacity of induced FOXP3 expressing
cells are due to different stimulation conditions or due to donor
dependent factors, it is now becoming increasingly accepted that
stable FOXP3 expression is a prerequisite for a suppressive
phenotype. We observed a significant difference in promoter
methylation status between naturally occurring and induced
CD4
+CD25
hi cells. This implicates that the partially methylated
state in the promoter region of CD4
+CD25
lo and induced
CD4
+CD25
hi cells could be the cause for the transient FOXP3
expression in these cells. The restriction enzyme based screening
method we describe provides a helpful tool for determination of
Treg commitment as well as optimization of culturing conditions
for Treg generation.
To illustrate how this method may be used, we measured
FOXP3 expression in activated CD25
lo cells and correlated this to
methylation level as well as suppressive capacity. A stimulated
culture will after a certain time contain activated, not yet activated
and formerly activated T cells, a fact which could explain the
differing results obtained by others when analyzing these cells [13–
15,17]. To reduce the heterogeneity of the tested populations the
activated T cells were sorted into CD25
hi and CD25
lo fractions
throughout the course of stimulation prior to methylation analysis.
A demethylated pattern was observed at an earlier stage in the
sorted CD25
hi populations (Figure 6A), possibly due to FOXP3’s
linkage to expression of the IL-2R alpha chain (CD25) i.e. higher
affinity to IL-2 and faster proliferative response. The association of
proliferation to the gradual demethylation observed implies a cell
division dependent passive demethylation process. It is interesting
to note that the level of methylation in sorted CD25
hi and lo,
CD25
lo derived, populations converges and levels off at a partial
demethylation around 60%. This convergence suggests that
although the fast and slow responding cells within the CD25
lo
population initially differed in methylation status, the induced
CD25
hi cells retain their partially demethylated conformation as
they downregulate CD25. In agreement with previous results,
FOXP3 expression was higher in the CD25
hi population
throughout the culture, and greater suppressive capacity was
observed in these cells (Figure 6C).
In addition, we investigated the effect on methylation status of a
spectrum of different stimuli and culturing conditions. Long-term
follow-up after stimulation as well as subjection of CD4
+CD25
lo
cells to repeated stimuli revealed a partial demethylation of the
277 reporter position. The addition of TGF-b and/or IL-10 did
not result in any evident additional demethylation. The restriction
enzyme based method allowed us to speed up the analysis, and
thus allowed inclusion of considerably more culture conditions and
time points than would have been practically possible with
conventional bisulphite sequencing.
The chromatin structure of the FOXP3 promoter region in
CD4
+CD25
hi, CD4
+CD25
lo and naı ¨ve CD4
+ cells has been shown
to have an open configuration, as defined by histone H4
acetylation analysis [11]. This accessibility was further increased
upon activation of CD4
+CD25
2 cells, an observation which
suggested that CD4
+CD25
2 cells harbour a chromatin confor-
mation which allows acquisition of a regulatory phenotype upon
activation. Histone acetylation is a dynamic process, which
provides a level of epigenetic regulation that is more likely to be
affected during short term induction than CpG methylation [26].
Upon stimulation of CD4
+CD25
lo cells demethylation occurs,
although not reaching a fully demethylated pattern as we observe
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activated CD4
+CD25
lo cells possess a chromatin structure which
permits FOXP3 expression but is limited by the methylation status
of the promoter. In developing immune cells, demethylation
during cell fate decisions occurs either passively through exclusion
of maintenance methylases from the replication fork [26], or
actively as in the case of IL-2 where a yet not identified enzyme is
able to actively demethylate the promoter region upon TCR
stimulation [40]. Our data shows that activation of CD4
+CD25
lo
cells results in partial demethylation of the human FOXP3
promoter, and that the speed of demethylation seems to correlate
to proliferation thus indicating passive demethylation. COBRA
based analysis of the 277 reporter position opens up for screening
of the methylation status in cell populations, and future
experiments will reveal whether other stimuli than the ones
investigated in this paper may result in full demethylation and
stable FOXP3 expression.
The observations of variable suppressive capacity of Treg
expansions [14] raise the question of which cells to use in
expansion protocols. Possibly, only a hitherto unidentified
subpopulation of circulating CD4
+ cells posses a predisposed
epigenetic architecture at the FOXP3 locus which makes them
suitable for expansions. Here, we identify the CpG position that
best discriminates committed Tregs from transiently FOXP3
expressing CD4
+ T cells, and introduce a method for convenient
methylation screening of this site. In conclusion, we propose that
the FOXP3 promoter is under strict epigenetic control and that
determination of the methylation status in the FOXP3 promoter
provides a more accurate definition of a suppressive phenotype in
Tregs than FOXP3 expression alone. These considerations
implicate CpG methylation analysis as a valuable tool for the
distinction of committed human Tregs in both clinical and in vitro
systems.
Materials and Methods
Isolation of Cell Populations
All procedures were done with approval from the Stockholm
north regional ethic committee. Blood samples were drawn from
healthy donors after written informed consent. CD4
+ cells were
purified using an autoMACS Separator (Miltenyi Biotec) and
CD4
+ T Cell Biotin-Antibody Cocktail and anti-biotin MicroBe-
ads alternatively anti-human CD4 MicroBeads. For proliferation
assay, this was followed by isolation of CD4
+CD25
+ cells with anti-
CD25 MicroBeads. B cells were isolated with anti-CD19 PE
antibodies (BD Biosciences PharMingen) and anti-PE microbeads
(Miltenyi Biotec). CD4
+CD25
hi and CD4
+CD25
lo cells were
isolated with the FACS Aria. All populations confirmed to be
.95% pure. Cells in culture were kept at 37uC in RPMI medium
(Invitrogen) containing 10% HuS, 1% PeSt, 1% Glutamine and
180 U rIL-2, alternatively AIM V medium (Invitrogen) +/2 10%
FCS and 180 U rIL-2.
Flow Cytometry
Peripheral blood mononuclear cells (PBMC) from healthy blood
donors were purified from buffy coats using Ficoll-Paque Plus
(Amersham Biosciences) according to manufacturer’s protocol.
Cells were labeled with surface antigen antibodies FITC-
conjugated anti-CD4 and anti-CD19, and PE-conjugated anti-
CD25 (BD Biosciences PharMingen), fixed and permeabilized
using the FOXP3 staining buffer set (eBioscience) and stained with
anti-FOXP3-APC according to manufacturer’s protocol. Samples
were run on either FACS Aria or FACS Calibur and analyzed
with FACS Diva and Cell Quest Pro Software respectively.
Stimulation of T cell cultures
CD4
+CD25
lo cells isolated from male donors were activated for
48 hours with anti-CD3/CD28 Dynabeads (Invitrogen) (propor-
tion cell:beads 1:1) in AIM-V containing 10% HUS, 180 U rIL-2
and 1% Penicillin Streptamycin (PeSt), after which the stimulus
was removed and cultures followed for an additional 14 days of
culture in AIM-V containing 10% HUS, 180 U rIL-2 and 1%
PeSt. Alternatively, cells isolated as above were grown in RPMI
containing 10% HUS, 180 U rIL-2 and 1% PeSt. In the specified
experiments, cells were stimulated with anti-CD3 (5 mg/mL) and
anti-CD28 (1 mg/mL) antibodies in the presence of 5 ng/mL
TGF-b and/or 10 ng/mL IL-10. For evaluation of the effect of
suboptimal versus conventional and high TCR-stimulus strength
10 mg/mL, 5 mg/mL and 0.5 mg/mL anti-CD3 antibody was
used in combination with 1 mg/mL anti-CD28, as well as separate
cultures with anti-CD3 (5 mg/mL) or anti-CD28 (1 mg/mL) only.
T Cell Proliferation Assay
Suppressive capacity was investigated either by incorporation of
[
3H]Thymidine or CFSE staining. For thymidine incorporation,
5*10
4 CD4
2 cells irradiated with 25 Gy were combined with 3*10
4
CD4
+CD25
2 responder cells and 1 mg/mL soluble CD28 in96-well
plates coated with 4 mg/mL anti-CD3 IgG. CD4
+CD25
+ cells were
added to the wells in relations varying from 1:1 to 1:4 to the
CD4
+CD25
2. Equal numbers of CD4
+CD25
2 cells were added to
the respondercellsinanadditionalset ofwellsas control.Allsamples
run in triplicate. Plates kept at 37uC for four or five days, pulsed with
[
3H]Thymidine for 18 h and frozen at 220uC. Cells were thawed
andthewellcontenttransferredtoaglassfibrefilter(Wallac)byacell
harvester (TOMTEC). MeltiLex A – Melt-on scintillator sheets
(Wallac)wereusedfordetectionofradioactivitywhichwasmeasured
using a 1205 Betaplate Liquid Scintillation Counter (Wallac).
The composition of the CFSE assays was as above except that
no cells were irradiated and the responder population was stained
with CFSE prior to setup. Proliferation was evaluated on day 4 as
a decrease of MFI within the positive population in FL-1 with
responder cells only as positive control.
RNA isolation and Reverse Transcriptase Quantitative
Real time PCR
RNA extraction was performed with the RNA Mini Kit (Bio-
Rad) alternatively with the use of TRIZOL reagent (Invitrogen),
and cDNA synthesis was carried out with iScript cDNA Synthesis
Kit (Bio-Rad) according to the manufacturer’s protocol. Quanti-
tative PCR was performed on an iCyclerIQ, and cycle thresholds
were obtained using iCycler IQ
TM Optical System Software
Version 3.1 from BIO-RAD. There have been several reports
about the questionable reliability of different housekeeping genes
[41,42]. In an extensive study by Radonic et al [42] RNA
polymerase II (RPII) was found to be the most reliable in a wide
variety of cell types including lymphocytes and thus this was our
choice of housekeeping gene. Expression levels were normalized to
RPII using the 2
2DDCt method. Primers were obtained from
Cybergene AB (Table 2). For ordinary PCR, ThermoPol Reaction
Buffer and Taq DNA polymerase (New England Biolabs) was used
whereas iQSYBR Green Supermix (Bio-Rad) was used in
quantitative real time PCR. The reactions were carried out in
MyCycler Thermal Cycler or iCycler iQ Real-Time PCR
Detection System (Bio-Rad).
DNA isolation and methylation analysis
Methylation analysis was carried out using bisulphite sequenc-
ing. Genomic DNA from cell populations isolated from male
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and bisulphite converted using EZ DNA Methylation Kit (ZYMO
Research) according to the manufacturer’s instruction. This
reaction converts all non-methylated cytosine bases into uracil.
The FOXP3 promoter region was amplified by PCR using
primers shown in Table 2 and PCR products were cloned into a
pCRH4-TOPOH vector using a TOPO TA CloningH Kit
(Invitrogen). DNA from individual bacterial clones was then
included in sequencing reactions with T3 and T7 primers using
BigDyeH Terminator v1.1 Cycle Sequencing Kit (Applied
Biosystems) according to manufacturer’s instruction. Samples
were examined on a 310 Genetic Analyzer (Applied Biosystems)
and resulting sequences analyzed using ABI Prism Sequencing
Analysis Software 3.7 (Applied Biosystems).
Bioinformatics
Information regarding conserved regions in the FOXP3
promoter was acquired from the UCSC Genome Bioinformatics
Site (http://genome.ucsc.edu/), and analyzed with regard to CpG
dinucleotides using the program ApE v1.10.1. Sequence alignment
for conservation analysis was performed using m-Vista genome
browser (http://genome.lbl.gov/vista/index.shtml) and ClustalW
(http://www.ebi.ac.uk/clustalw/). Statistical analysis of obtained
data was performed using Fisher’s exact test.
Combined Bisulphite Restriction Enzyme Analysis
(COBRA)
Genomic DNA was isolated and bisulphite treated as previously
described. The FOXP3 promoter region was amplified by PCR
with a nonconjugated forward primer and a 59 6-FAM conjugated
reverse primer shown in Table 2. PCR products were digested
with Aci1 in excess. Following a phenol chlorofom extraction
digested products were loaded onto a 310 Genetic Analyzer
(Applied Biosystems) and fragment analysis was performed using
Gene Scan v3.7 application software (Applied Biosystems). As
controls for validity of the COBRA reaction M.Sss1 (New England
Biolobs) treated DNA from a bacterial artificial chromosome
(BAC) containing the FOXP3 locus (RP11-528A24, BACPAC
Resources, CHORI) and unmodified BAC DNA were used.
Supporting Information
Table S1 P-value for each CpG position during T cell
activation.
Found at: doi:10.1371/journal.pone.0001612.s001 (0.03 MB
DOC)
Figure S1 Conservation of the FOXP3 promoter region.
ClustalW alignment indicating cross species conservation in the
FOXP3 promoter region. Stars under each nucleotide position
indicate full conservation. Aligned score indicate cross species
conservation in percent.
Found at: doi:10.1371/journal.pone.0001612.s002 (0.96 MB TIF)
Figure S2 Conservation of the FOXP3 promoter CpG contain-
ing region. ClustalW alignment as described in Figure S1
including only the CpG containing region of the FOXP3 promoter.
Found at: doi:10.1371/journal.pone.0001612.s003 (0.51 MB TIF)
Figure S3 Methylation of the FOXP3 promoter during stimu-
lation of CD4
+CD25
lo cells from one male donor. (A)
CD4
+CD25
lo cells were stimulated with CD3/CD28 dynabeads
as described in Figure 5 and DNA extracted at day 0, 2 and 12 for
bisulphite sequencing. Figures illustrating methylation at indicated
sites as previously described in Figure 3. (B) Methylation status of
CpG positions of sorted CD4
+CD25
lo and CD4
+CD25
hi cells on
day 13 of culture.
Found at: doi:10.1371/journal.pone.0001612.s004 (1.15 MB TIF)
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